Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Pemetrexed in Patients With Advanced Neuroendocrine Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00424723
Recruitment Status : Completed
First Posted : January 19, 2007
Last Update Posted : August 12, 2010
Beth Israel Deaconess Medical Center
Brigham and Women's Hospital
Massachusetts General Hospital
Information provided by:
Dana-Farber Cancer Institute